OBJECTIVES: To examine the risks of intra-uterine (IU), intra- and early post-partum (IP/ePP) and late post-partum (LPP) mother-to-child transmission (MTCT) of HIV-1 and infant mortality in the first 6 months of life. METHODS: Whole blood was collected in ethylenediaminetetra-acetic acid at birth, 6 weeks, 3 and 6 months from 996 infants born to HIV-1 seropositive mothers. Polymerase chain reaction using Roche DNA amplification assay, version 1.5 (Roche Diagnostics Incorporation, Alameda, California, USA) was used to determine timing of MTCT. Logistic regression models determined risk factors for HIV-1 transmission and survival analyses examined mortality by timing of transmission. RESULTS: Two hundred and forty-nine mothers (30.7%) transmitted HIV-1 infection to their infants by 6 months of age. Eighty-nine infants [9.4%; 95% confidence interval (CI), 7.7-11.5], 104 infants (16.0%; 95% CI, 10.8-21.2) and 21 infants (5.3%; 95% CI, 1.6-12.2) were infected IU, IP/ePP and LPP respectively. Low maternal CD4 cell count and arm circumference were risk factors for IP/ePP transmission. Infant mortality was higher among infected infants than uninfected (P < 0.001, log rank test). Timing of infection, birth weight and maternal CD4 cell counts were important factors in predicting infant death. CONCLUSION: In the first 6 months of life, IU and IP/ePP transmission contributed more than three-quarters of the 30.7% MTCT. Our data, in addition to serving as a historical comparison, may be useful in designing and evaluating the efficacy of short course antiretroviral trials aimed at reducing MTCT in developing countries.
OBJECTIVES: To examine the risks of intra-uterine (IU), intra- and early post-partum (IP/ePP) and late post-partum (LPP) mother-to-child transmission (MTCT) of HIV-1 and infant mortality in the first 6 months of life. METHODS: Whole blood was collected in ethylenediaminetetra-acetic acid at birth, 6 weeks, 3 and 6 months from 996 infants born to HIV-1 seropositive mothers. Polymerase chain reaction using Roche DNA amplification assay, version 1.5 (Roche Diagnostics Incorporation, Alameda, California, USA) was used to determine timing of MTCT. Logistic regression models determined risk factors for HIV-1 transmission and survival analyses examined mortality by timing of transmission. RESULTS: Two hundred and forty-nine mothers (30.7%) transmitted HIV-1 infection to their infants by 6 months of age. Eighty-nine infants [9.4%; 95% confidence interval (CI), 7.7-11.5], 104 infants (16.0%; 95% CI, 10.8-21.2) and 21 infants (5.3%; 95% CI, 1.6-12.2) were infected IU, IP/ePP and LPP respectively. Low maternal CD4 cell count and arm circumference were risk factors for IP/ePP transmission. Infant mortality was higher among infected infants than uninfected (P < 0.001, log rank test). Timing of infection, birth weight and maternal CD4 cell counts were important factors in predicting infant death. CONCLUSION: In the first 6 months of life, IU and IP/ePP transmission contributed more than three-quarters of the 30.7% MTCT. Our data, in addition to serving as a historical comparison, may be useful in designing and evaluating the efficacy of short course antiretroviral trials aimed at reducing MTCT in developing countries.
Authors: Alexander C Ewing; Sascha R Ellington; Jeffrey B Wiener; Charles S Chasela; Gerald Tegha; Julie A E Nelson; Denise J Jamieson; Charles van der Horst; Athena P Kourtis Journal: Pediatr Infect Dis J Date: 2019-05 Impact factor: 2.129
Authors: Matthew P Fox; Daniel Brooks; Louise Kuhn; Grace Aldrovandi; Moses Sinkala; Chipepo Kankasa; Mwiya Mwiya; Robert Horsburgh; Donald M Thea Journal: J Acquir Immune Defic Syndr Date: 2008-05-01 Impact factor: 3.731
Authors: Kerina Duri; Felicity Z Gumbo; Knut I Kristiansen; Nyaradzi E Kurewa; Munyaradzi P Mapingure; Simbarashe Rusakaniko; Mike Z Chirenje; Fredrik Muller; Babill Stray-Pedersen Journal: Virol J Date: 2010-08-02 Impact factor: 4.099
Authors: F Z Gumbo; K Duri; G Q Kandawasvika; N E Kurewa; M P Mapingure; M W Munjoma; S Rusakaniko; M Z Chirenje; B Stray-Pedersen Journal: J Perinatol Date: 2010-03-25 Impact factor: 2.521
Authors: Adam R Aluisio; Rose Bosire; Betz Bourke; Ann Gatuguta; James N Kiarie; Ruth Nduati; Grace John-Stewart; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Saurabh Mehta; Karim P Manji; Alicia M Young; Elizabeth R Brown; Charles Chasela; Taha E Taha; Jennifer S Read; Robert L Goldenberg; Wafaie W Fawzi Journal: Am J Clin Nutr Date: 2008-06 Impact factor: 7.045
Authors: Rashida A Ferrand; Elizabeth L Corbett; Robin Wood; John Hargrove; Chiratidzo E Ndhlovu; Frances M Cowan; Eleanor Gouws; Brian G Williams Journal: AIDS Date: 2009-09-24 Impact factor: 4.177